Prof. Joshua Guetzkow uncovers CDC’s OWN incriminating DATA, via VAERS,” Professor Joshua Guetzkow brings attention to several concerning safety signals found in the CDC’s COVID-19 vaccine data obtained through the Vaccine Adverse Events Reporting System (VAERS). The video sheds light on adverse events that have been largely disregarded by the CDC and FDA, including inflammation-related issues like myocarditis and pericarditis, as well as other serious adverse reactions. This article will delve deeper into the key points raised in the video and explore the implications of the CDC’s handling of vaccine data.
Table of contentsIntroductionThe significance of safety signalsAdverse events reported through VAERSFocus on cardiovascular and neurological adverse eventsAdverse events in the 12 to 17 age groupInflammation as a side effect of the COVID-19 vaccineFailure to consider the well-being of teenagersMisinterpretation of safety signalsUnderreporting of adverse events in IsraelConclusionFAQsRelated Articles
Introduction
Professor Joshua Guetzkow reveals his findings after conducting a thorough examination of the CDC’s COVID-19 vaccine data obtained through the VAERS system. The analysis uncovers several safety signals that have been overlooked or downplayed by the CDC and FDA.
The significance of safety signals
Safety signals are crucial indicators of potential adverse reactions to vaccines. They help identify any risks associated with vaccination and allow for timely intervention to ensure public safety. Professor Guetzkow emphasizes the importance of thoroughly investigating safety signals to protect the well-being of vaccine recipients.
Adverse events reported through VAERS
The VAERS system has revealed a significant number of adverse events associated with COVID-19 vaccination. These events range from blood clotting and stroke to Bell’s palsy, genital ulcerations, and immune thrombocytopenia. Of particular concern is the higher reporting rate of adverse events in the 12 to 17 age group, indicating a need for closer scrutiny and consideration of the younger demographic’s well-being.
Focus on cardiovascular and neurological adverse events
Professor Guetzkow highlights the prevalence of adverse events related to the cardiovascular and neurological systems. Reports have shown chest pain, palpitations, atrial fibrillations, cardiac failure, tinnitus (associated with increased suicide risk), Bell’s palsy, dementia, and paresthesia. These adverse events raise concerns about the safety of the COVID-19 vaccine and warrant further investigation.
Adverse events in the 12 to 17 age group
The data obtained through a Freedom of Information Act (FOIA) request reveals a higher incidence of adverse events in the 12 to 17 age group. Despite these concerning findings, the CDC and FDA have largely disregarded the signals, leaving questions about their approach to ensuring the safety of younger vaccine recipients.
Inflammation as a side effect of the COVID-19 vaccine
Inflammation, particularly myocarditis and pericarditis, has emerged as a side effect of the COVID-19 vaccine. Professor Guetzkow explains how inflammation can be both beneficial and harmful but emphasizes that unnecessary inflammation caused by the vaccine raises concerns. The impact on younger age groups, such as 5 to 11-year-olds, is particularly alarming.
Failure to consider the well-being of teenagers
The CDC’s response to the pandemic has been criticized for its failure to adequately consider the well-being of teenagers. Despite a high percentage of teenagers being hospitalized after receiving the COVID-19 vaccine, the committee responsible for vaccine safety only focused on myocarditis and neglected other serious symptoms. This raises questions about the CDC’s approach to ensuring the safety of this vulnerable population.
Misinterpretation of safety signals
The CDC defines safety signals for new vaccines by comparing them to …
Discover more from Randy Bock MD PC
Subscribe to get the latest posts sent to your email.
